RXBIOLOGICS LIMITED

Active Cambridge

Research and experimental development on biotechnology

19 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
R

RXBIOLOGICS LIMITED

Research and experimental development on biotechnology

Founded 30 Jan 2017 Active Cambridge, England 19 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology

Previous Company Names

RX&D LIMITED 30 Jan 2017 — 7 Feb 2019
Accounts Submitted 14 Aug 2025 Next due 31 Aug 2026 4 months remaining
Confirmation Submitted 11 Feb 2026 Next due 12 Feb 2027 9 months remaining
Net assets £-1M £571K 2024 year on year
Total assets £752K £189K 2024 year on year
Total Liabilities £2M £759K 2024 year on year
Charges 1
1 satisfied

Contact & Details

Contact

Registered Address

The Dorothy Hodgkin Building Babraham Research Campus Babraham Cambridge CB22 3FH England

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for RXBIOLOGICS LIMITED (10590235), an active life sciences and medical technology company based in Cambridge, England. Incorporated 30 Jan 2017. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2017–2024)

Cash in Bank

£23.12k

Increased by £13.43k (+139%)

Net Assets

-£1.31M

Decreased by £570.58k (-77%)

Total Liabilities

£2.07M

Increased by £759.16k (+58%)

Turnover

N/A

Employees

19

Increased by 4 (+27%)

Debt Ratio

275%

Increased by 43 (+19%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

2 Allotments 80,199 Shares £80k Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
29 Jul 2019200£200£1
29 Mar 201779,999£80k£80k

Officers

Officers

3 active
Status
Elaine MckilliginSecretaryUnknownUnknown30 Jan 2017Active
Grainger, David John, DrDirectorBritishEngland591 Mar 2017Active
Grainger, Elaine, DrDirectorBritishEngland581 Mar 2017Active

Shareholders

Shareholders (2)

Rxcelerate Limited
80.0%
Wjfinlay Consulting Limited
20.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active

Rxcelerate Limited

United Kingdom

Active
Notified 30 Jan 2017
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Group Structure

Group Structure

RXCELERATE LIMITED united kingdom
RXBIOLOGICS LIMITED Current Company

Charges

Charges

1 satisfied

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
11 Feb 2026Confirmation StatementConfirmation statement made on 2026-01-29 with no updates
11 Feb 2026OfficersChange to director Dr Elaine Mckilligin on 2026-02-01
14 Aug 2025AccountsAnnual accounts made up to 2024-11-30
11 Feb 2025Confirmation StatementConfirmation statement made on 2025-01-29 with no updates
27 Aug 2024AccountsAnnual accounts made up to 2023-11-30
11 Feb 2026 Confirmation Statement

Confirmation statement made on 2026-01-29 with no updates

11 Feb 2026 Officers

Change to director Dr Elaine Mckilligin on 2026-02-01

14 Aug 2025 Accounts

Annual accounts made up to 2024-11-30

11 Feb 2025 Confirmation Statement

Confirmation statement made on 2025-01-29 with no updates

27 Aug 2024 Accounts

Annual accounts made up to 2023-11-30

Recent Activity

Latest Activity

Confirmation statement made on 2026-01-29 with no updates

2 months ago on 11 Feb 2026

Change to director Dr Elaine Mckilligin on 2026-02-01

2 months ago on 11 Feb 2026

Annual accounts made up to 2024-11-30

8 months ago on 14 Aug 2025

Confirmation statement made on 2025-01-29 with no updates

1 years ago on 11 Feb 2025

Annual accounts made up to 2023-11-30

1 years ago on 27 Aug 2024